These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9408071)

  • 21. Relationship between sodium-lithium countertransport and insulin sensitivity in mild hypertension.
    Herlitz H; Landin K; Widgren B
    J Intern Med; 1996 Mar; 239(3):235-40. PubMed ID: 8772622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long term cardiovascular effects of oral antidiabetic agents in non-diabetic patients with insulin resistance: double blind, prospective, randomised study.
    Stakos DA; Schuster DP; Sparks EA; Wooley CF; Osei K; Boudoulas H
    Heart; 2005 May; 91(5):589-94. PubMed ID: 15831640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
    Lacourcière Y; Asmar R
    Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone.
    Antonucci T; Whitcomb R; McLain R; Lockwood D; Norris RM
    Diabetes Care; 1997 Feb; 20(2):188-93. PubMed ID: 9118772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Night-time ambulatory blood pressure is the best pretreatment blood pressure predictor of 11-year mortality in treated older hypertensives.
    Wing LMH; Chowdhury EK; Reid CM; Beilin LJ; Brown MA;
    Blood Press Monit; 2018 Oct; 23(5):237-243. PubMed ID: 29864033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.
    Hermann LS; Scherstén B; Bitzén PO; Kjellström T; Lindgärde F; Melander A
    Diabetes Care; 1994 Oct; 17(10):1100-9. PubMed ID: 7821128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automatic office blood pressure measured without doctors or nurses present.
    Ishikawa J; Nasothimiou EG; Karpettas N; McDoniel S; Feltheimer SD; Stergiou GS; Pickering TG; Schwartz JE
    Blood Press Monit; 2012 Jun; 17(3):96-102. PubMed ID: 22425703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin and diastolic dysfunction in lean and obese hypertensives: genetic influence.
    Grandi AM; Zanzi P; Fachinetti A; Gaudio G; Ceriani L; Bertolini A; Guasti L; Venco A
    Hypertension; 1999 Dec; 34(6):1208-14. PubMed ID: 10601120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of masked hypertension and the 'mask effect' in patients with well-controlled office blood pressure.
    Park SJ; Park JB; Choi DJ; Youn HJ; Park CG; Ahn YK; Shin JH; Kim DW; Rim SJ; Bae JH; Park HY;
    Circ J; 2011; 75(2):357-65. PubMed ID: 21048328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated office blood pressure measurements in primary care are misleading in more than one third of treated hypertensives: The VALENTINE-Greece Home Blood Pressure Monitoring study.
    Kollias A; Papadatos SS; Dominiczak AF; Parati G; Stergiou GS;
    Hellenic J Cardiol; 2020; 61(3):174-177. PubMed ID: 30639355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between serum lipids, glucose tolerance, and insulin sensitivity during 12 months of celiprolol treatment.
    Malminiemi K
    Cardiovasc Drugs Ther; 1995 Apr; 9(2):295-304. PubMed ID: 7662596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives.
    Feldstein CA; Renauld A; Akopian M; Olivieri AO; Garrido D
    J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.
    Abbasi F; Kamath V; Rizvi AA; Carantoni M; Chen YD; Reaven GM
    Diabetes Care; 1997 Dec; 20(12):1863-9. PubMed ID: 9405908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial.
    Rissanen A; Howard CP; Botha J; Thuren T;
    Diabetes Obes Metab; 2012 Dec; 14(12):1088-96. PubMed ID: 22726220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramine.
    Derosa G; Mereu R; Salvadeo SA; D'Angelo A; Ciccarelli L; Piccinni MN; Ferrari I; Gravina A; Maffioli P; Cicero AF
    Intern Med; 2009; 48(5):265-71. PubMed ID: 19252346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamic effects of rosiglitazone in nondiabetic patients with metabolic syndrome.
    Aquilante CL; Kosmiski LA; Zineh I; Rome LC; Knutsen SD
    Pharmacotherapy; 2010 Mar; 30(3):236-47. PubMed ID: 20180607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary nitrate lowers ambulatory blood pressure in treated, uncontrolled hypertension: a 7-d, double-blind, randomised, placebo-controlled, cross-over trial.
    Kerley CP; Dolan E; James PE; Cormican L
    Br J Nutr; 2018 Mar; 119(6):658-663. PubMed ID: 29553033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of grape seed extract beverage on blood pressure and metabolic indices in individuals with pre-hypertension: a randomised, double-blinded, two-arm, parallel, placebo-controlled trial.
    Park E; Edirisinghe I; Choy YY; Waterhouse A; Burton-Freeman B
    Br J Nutr; 2016 Jan; 115(2):226-38. PubMed ID: 26568249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.
    Moghetti P; Castello R; Negri C; Tosi F; Perrone F; Caputo M; Zanolin E; Muggeo M
    J Clin Endocrinol Metab; 2000 Jan; 85(1):139-46. PubMed ID: 10634377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperinsulinemia, family history of hypertension, and essential hypertension.
    Grandi AM; Gaudio G; Fachinetti A; Bianchi L; Nardo B; Zanzi P; Ceriani L; Guasti L; Venco A
    Am J Hypertens; 1996 Aug; 9(8):732-8. PubMed ID: 8862218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.